Lifitegrast is a prescription eye drop used to treat dry eye disease. It works by calming the swelling and irritation on the surface of the eye that can make eyes feel dry, gritty or sore. It's used as one drop in each eye twice a day.
Every report comes from a Lived member, sent anonymously.
Have you tried Xiidra (Lifitegrast) for Dry Eye?
Lifitegrast, sold as Xiidra, is a prescription eye drop for dry eye disease in adults. It is approved to treat both the symptoms people feel, such as dryness, grittiness and burning, and the signs an eye doctor sees on the surface of the eye. Dry eye disease is more than a shortage of tears. When the tear film is unstable or too thin, the surface of the eye becomes irritated and inflamed, and that inflammation in turn makes the tear film worse. Artificial tears ease the feeling of dryness for a while but do not treat the inflammation. Lifitegrast is one of the prescription drops aimed at that underlying inflammation, alongside cyclosporine eye drops, and is often tried when artificial tears alone are not enough. It has not been shown to be safe or effective in children and teens under 17.
In dry eye disease, white blood cells called T cells gather in the tissues on the front of the eye and release chemical signals that keep inflammation going. To stick to those tissues and become active, T cells use a surface protein called LFA-1 (lymphocyte function-associated antigen-1), which latches onto a partner protein, ICAM-1, that is often increased on the dry eye's surface. Lifitegrast blocks LFA-1 from binding to ICAM-1. In laboratory studies, this reduced T cells' ability to attach and lowered the release of inflammatory signals. The idea is that calming this cycle lets the eye's surface and tear film recover. Researchers do not know exactly how much of the drug's benefit comes from this mechanism, and it does not add moisture the way artificial tears do.
Xiidra comes as a 5% solution in small single-use containers. The usual routine is one drop in each eye twice a day, about 12 hours apart. One container holds enough for both eyes; use it right away after opening and throw it away afterward, even if some liquid is left, rather than saving it for later. Do not let the tip of the container touch the eye or any other surface, which can injure the eye or contaminate the drop. Take contact lenses out before using it and wait 15 minutes before putting them back in. Keep unopened containers in their foil pouch, which protects them from light. If you use other eye drops, tell your prescriber so they can advise how to fit them into your routine.
The most common effects happen right when the drop goes in: irritation, stinging or discomfort in the eye, and blurred or reduced vision for a short time. About one in seven people notice an unusual taste in the mouth after a dose. Less common effects include red eyes, watery eyes, eye itching or discharge, headache and sinus inflammation. Most reactions are mild to moderate, and in trials the stinging tended to ease within a few minutes of each dose. Still, roughly 7 in 100 people stopped treatment because of side effects, compared with about 3 in 100 using a placebo drop. Tell your prescriber about any side effect that bothers you. Serious allergic reactions are rare but have been reported. Wheezing, difficulty breathing, or swelling of the tongue or throat after using the drops needs emergency care right away; call 911. A rash or swelling around the eyes should also be reported promptly.
Do not use Xiidra if you have had an allergic reaction to lifitegrast or any of its other ingredients. Because only a very small amount reaches the bloodstream, no specific drug interactions are listed on the label, but your prescriber and pharmacist should know about every eye drop you use, including over-the-counter lubricants. There is no information on using Xiidra during pregnancy. Animal studies found harm only at exposures hundreds of times higher than eye drops produce, so the relevance to people is unclear. It is also not known whether lifitegrast passes into breast milk. If you are pregnant, planning a pregnancy or breastfeeding, discuss whether the expected benefit justifies using it.
Lifitegrast is a treatment you use every day, not a drop for occasional relief. In clinical trials some people noticed less dryness within two weeks, and the difference from a placebo drop was clear by six weeks. The improvement was real but moderate: on a 0 to 100 dryness scale, people using lifitegrast improved by roughly 7 to 13 points more than people using the placebo drop. Its effect on the visible surface damage an eye doctor measures was less consistent than its effect on symptoms. Response varies, and not everyone with dry eye benefits. Your eye doctor will usually reassess how your eyes feel and look after a few months. Because dry eye disease is generally a long-term condition, symptoms may return if you stop, so people who do well often continue. Other treatments, such as cyclosporine drops, may be used instead, and many people keep using artificial tears for comfort.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience taking Xiidra (Lifitegrast), what you've noticed, or ask the community a question.